Overactive Bladder - Results from #2360

The natural history of the overactive bladder syndrome in females: A long-term analysis of a health screening project - Abstract June 27, 2011

Neuromodulation for intractable OAB - Abstract June 24, 2011

Constructing trials to show whether urodynamic studies are necessary in lower urinary tract dysfunction - Abstract June 23, 2011

Is sensory testing during lead placement crucial for achieving positive outcomes after sacral neuromodulation? - Abstract June 23, 2011

Editor's Commentary - Perceptions of "urgency" in women with interstitial cystitis/bladder pain syndrome or overactive bladder June 23, 2011

Urinary dysfunction in early and untreated Parkinson's disease - Abstract June 22, 2011

SUFU 2011 - Sanctura XR muscarinic anatagonist resist transport (SMART) across the blood-brain barrier (BBB): A prospective neurocognitive biodistribution and pharmacokinetic study of extended release trospium - Session Highlights June 21, 2011

Review of fesoterodine - Abstract June 15, 2011

SUFU 2011 - Open forum: New disease in town - Session Highlights June 15, 2011

Role of botulinum toxin-A in refractory idiopathic overactive bladder patients without detrusor overactivity. - Abstract June 14, 2011

Antimuscarinic drugs: Review of the cognitive impact when used to treat overactive bladder in elderly patients - Abstract June 6, 2011

Solifenacin as add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms-ASSIST, randomized controlled study - Abstract June 3, 2011

Cost-effectiveness analysis of antimuscarinics in the treatment of patients with overactive bladder in Spain: A decision-tree model - Abstract May 31, 2011

Urgency severity scale could predict urodynamic detrusor overactivity in patients with overactive bladder syndrome - Abstract May 30, 2011

Efficacy of solifenacin on nocturia in Japanese patients with overactive bladder: Impact on sleep evaluated by bladder diary - Abstract May 29, 2011

Bladder base/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinics - Abstract May 27, 2011

Effects of voluntary dose escalation in a placebo-controlled, flexible-dose trial of fesoterodine in subjects with overactive bladder - Abstract May 26, 2011

Correlation between improvements in overactive bladder symptom score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug - Abstract May 25, 2011

Is endoscopic injection therapy a reasonable treatment option for low-grade vesicoureteral reflux in association with overactive bladder? - Abstract May 24, 2011

Reproducibility of urodynamic filling sensation at weekly interval in healthy volunteers and in women with detrusor overactivity - Abstract May 23, 2011

Page 119 of 122